General Announcement::Settlement and delisting

Issuer & Securities

Issuer/ Manager
GLENMARK PHARMACEUTICALS LIMITED
Securities
GLENMARK PHARM US$170M2%220628 - XS1426780125 - 4G8B
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-May-2022 01:19:04
Status
New
Announcement Sub Title
Settlement and delisting
Announcement Reference
SG220510OTHRFTK6
Submitted By (Co./ Ind. Name)
Glenmark Pharmaceuticals Limited
Designation
Company Secretary & Compliance Officer
Effective Date and Time of the event
09/05/2022 00:00:00
Description (Please provide a detailed description of the event in the box below)
Settlement of USD 0.75 Mn

Attachments

SGX_09052022.pdf
Total size =77K